Literature DB >> 18544747

ROCO kinase activity is controlled by internal GTPase function.

Bertram Weiss1.   

Abstract

Small guanosine triphosphatases (GTPases) have long been known to control the activities of downstream protein kinases. Some members of a rather new multidomain protein family contain not only a GTPase domain of the ROC (Ras of complex protein) subtype but also a protein kinase domain, and both domains seem to cooperate with each other in the same polypeptide. Data now show that the kinase activity of one of these ROCO proteins depends on whether guanosine diphosphate or guanosine triphosphate (GTP) is bound and that the activity is controlled by the adjacent GTPase, which suggests a novel mechanism of intrinsic control. This ROCO family member, leucine-rich repeat kinase 2 (LRRK2), is of special interest because mutations within both its protein kinase and its GTPase domains are associated with Parkinson's disease (PD). These mutations lead to abnormally enhanced protein kinase activity, which is believed to cause or at least contribute to neuronal damage. The crystal structure of the GTPase domain of LRRK2 has now been resolved and shows that the ROC GTPase domain is responsible for LRRK2 homodimerization in a surprising way. The structure not only offers insights into the molecular effects of some of the PD-associated mutations of LRRK2, but may also help to improve our understanding of the intrinsic control mechanism between a GTPase and a protein kinase within the same protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544747     DOI: 10.1126/scisignal.123pe27

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  7 in total

Review 1.  LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's disease.

Authors:  Yulan Xiong; Valina L Dawson; Ted M Dawson
Journal:  Biochem Soc Trans       Date:  2012-10       Impact factor: 5.407

2.  Parkinson's disease: leucine-rich repeat kinase 2 and autophagy, intimate enemies.

Authors:  José M Bravo-San Pedro; Rubén Gómez-Sánchez; Elisa Pizarro-Estrella; Mireia Niso-Santano; Rosa A González-Polo; José M Fuentes Rodríguez
Journal:  Parkinsons Dis       Date:  2012-08-30

3.  Efficient allele-specific targeting of LRRK2 R1441 mutations mediated by RNAi.

Authors:  Laura de Yñigo-Mojado; Itziar Martín-Ruíz; James D Sutherland
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

4.  Leucine-rich repeat kinase LRRK1 regulates endosomal trafficking of the EGF receptor.

Authors:  Hiroshi Hanafusa; Kouki Ishikawa; Shin Kedashiro; Tsukasa Saigo; Shun-Ichiro Iemura; Tohru Natsume; Masayuki Komada; Hiroshi Shibuya; Atsuki Nara; Kunihiro Matsumoto
Journal:  Nat Commun       Date:  2011-01-18       Impact factor: 14.919

5.  The R1441C mutation alters the folding properties of the ROC domain of LRRK2.

Authors:  Yongchao Li; Laura Dunn; Elisa Greggio; Brian Krumm; Graham S Jackson; Mark R Cookson; Patrick A Lewis; Junpeng Deng
Journal:  Biochim Biophys Acta       Date:  2009-09-23

6.  GTP binding and intramolecular regulation by the ROC domain of Death Associated Protein Kinase 1.

Authors:  Joseph D Jebelli; Sybille Dihanich; Laura Civiero; Claudia Manzoni; Elisa Greggio; Patrick A Lewis
Journal:  Sci Rep       Date:  2012-09-26       Impact factor: 4.379

Review 7.  Mitochondrial Function and Parkinson's Disease: From the Perspective of the Electron Transport Chain.

Authors:  Jeng-Lin Li; Tai-Yi Lin; Po-Lin Chen; Ting-Ni Guo; Shu-Yi Huang; Chun-Hong Chen; Chin-Hsien Lin; Chih-Chiang Chan
Journal:  Front Mol Neurosci       Date:  2021-12-09       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.